how does a glp 1 receptor agonist work The Impact of GLP-1 Agonists on Ocular Disease GLP−1 Receptor Agonist Mechanisms GLP−1RAs

Of 501 244 adverse reactions reported with diabetes drugs between 2007 and 2018, only 698 (1.4%) involved gastrointestinal stenosis and obstruction, of which 216 ( 0.04% of the total) were treated with GLP-1RAs

CAPTURE: a cross-sectional study of the contemporary (2019) prevalence of cardiovascular disease in adults with type 2 diabetes across 13 countries

However, regulatory guidance states that when the ratio of the area under the concentration-time curve (AUC) of the victim drug with and without the perpetrator drug falls outside the range of 0.81.25, there is a potential risk of a clinically significant impact, necessitating further investigation

4 Orforglipron continues to demonstrate notable glycemic and weight effects in phase II trials

doi: 10.3389/fimmu.2022.772446 27 RichardsPParkerHEAdriaenssensAEHodgsonJMCorkSCTrappSet al

doi:10.2337/db19-985-P 50